Detalles de la búsqueda
1.
Novel bivalent ligands carrying potential antinociceptive effects by targeting putative mu opioid receptor and chemokine receptor CXCR4 heterodimers.
Bioorg Chem
; 120: 105641, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35093692
2.
A Journey through Diastereomeric Space: The Design, Synthesis, In Vitro and In Vivo Pharmacological Activity, and Molecular Modeling of Novel Potent Diastereomeric MOR Agonists and Antagonists.
Molecules
; 27(19)2022 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36234992
3.
Role of efficacy as a determinant of locomotor activation by mu-opioid receptor (MOR) ligands in female and male mice. II. Effects of novel MOR-selective phenylmorphans with high-to-low MOR efficacy.
Pharmacol Res Perspect
; 11(4): e01111, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37381112
4.
Psychedelic-like Properties of Quipazine and Its Structural Analogues in Mice.
ACS Chem Neurosci
; 12(5): 831-844, 2021 03 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33400504
5.
Structure-Based Design and Development of Chemical Probes Targeting Putative MOR-CCR5 Heterodimers to Inhibit Opioid Exacerbated HIV-1 Infectivity.
J Med Chem
; 64(11): 7702-7723, 2021 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34027668
6.
Bivalent Ligand Aiming Putative Mu Opioid Receptor and Chemokine Receptor CXCR4 Dimers in Opioid Enhanced HIV-1 Entry.
ACS Med Chem Lett
; 11(11): 2318-2324, 2020 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33214847
Resultados
1 -
6
de 6
1
Próxima >
>>